Danny LiebermaninBack to the future of workMoneyball drug researchBaseball metrics for oncology clinical trials, is an idea I floated a few months ago to some colleagues in the drug research and…Sep 11, 2023Sep 11, 2023
Danny LiebermanYour next quality manager is an AIWYSINATI — what you see is not all there isSep 10, 2023Sep 10, 2023
Danny LiebermaninBack to the future of workThe manager jumps in anti-design pattern.In my previous post 2 Sure-fire ways to fail I introduced the notion of anti-design patterns. We introduced the RECYCLE and DFTBB (Don’t…Aug 28, 2023Aug 28, 2023
Danny LiebermaninBack to the future of workInformation junkiesInformation junkies exist everywhere. Maybe we are all addicted today. To the news. Social media. Research articles on AI.Aug 27, 2023Aug 27, 2023
Danny Lieberman2 sure-fire ways to fail any projectThere are Design patterns and Anti-design patternsAug 24, 2023Aug 24, 2023
Danny LiebermaninBack to the future of workYou do not need empathy to support customers.Empathy will not get you across a rocky road.Aug 17, 2023Aug 17, 2023
Danny LiebermaninBack to the future of workEpilepsy camp at the Jordan River Village5 days of serious funAug 16, 2023Aug 16, 2023
Danny LiebermaninBack to the future of workDoes AI improve patient safety outcomes or not?Does AI improve drug safety for patients or not?Aug 2, 2023Aug 2, 2023
Danny LiebermaninBack to the future of workThe best time in history for tech startupsNo. I am not painting a pink picture of the tough as nails tech industry.Jul 31, 2023Jul 31, 2023
Danny LiebermaninBack to the future of workOpen source has lapped big tech on AIWe have entered an era of LLM democratization.Jul 28, 2023Jul 28, 2023
